Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

mesolimbic dopamine system

Known as: mesolimbic system 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
ABSTRACT Haplotypes of the Gabra2 gene encoding the &agr;2‐subunit of the GABAA receptor (GABAAR) are associated with drug abuse… 
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
2016
2016
Although early rat studies demonstrated that administration of glucose diminishes dopaminergic midbrain activity, evidence in… 
Review
2008
Review
2008
Clinical trials are currently underway to determine the effectiveness of acupuncture in the treatment of drug addiction. While… 
  • figure 1
Highly Cited
2007
Highly Cited
2007
Chronic morphine administration induces functional and morphological alterations in the mesolimbic dopamine system (MLDS), which… 
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Review
1996
Review
1996
  • E. Kiyatkin
  • Neuroscience & Biobehavioral Reviews
  • 1996
  • Corpus ID: 24084256
Although a large body of neuropharmacological evidence suggests that the mesolimbic dopamine system (ML DA) is critical for goal… 
Highly Cited
1996
Highly Cited
1996
Following the conduct of a 28-day inpatient bioequivalence study of clozapine in schizophrenia patients, withdrawal effects after… 
1995
1995
Four experiments were designed to study the ability of 0.5 g/kg ethanol (EtOH) intraperitoneally to modify locomotor activity… 
1982
1982
The presence of high and low affinity 3H-spiperone binding sites was demonstrated in both the rat striatum and mesolimbic area… 
Highly Cited
1980
Highly Cited
1980
Tardive dyskinesia is thought to result from neostriatal dopaminergic receptor supersensitivity induced by chronic treatment with… 
  • table 1
1979
1979
The effect of chronic neuroleptic drug treatment on self-stimulation of the mesolimbic dopamine system was tested. Rats with…